HMGB1 and melanoma: By inhibiting oxygen-sensitive prolyl hydroxylases (PHDs) with DMOG, we observed that the resulting increased stabilization of HIF1α (Fig. 3d) was associated with a higher HMGB1 release in melanoma cell lines (Fig. 3e).